Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07754474 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Test How Well Different and Multiple Doses of BI 3034701 Are Tolerated in People Living With Overweight or Obesity

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 5 months later Jan 17, 2027 → Jun 21, 2027
See other at-risk trials from Boehringer Ingelheim

Record History

See every version on ClinicalTrials.gov ↗

  1. Recruitment opened
    • Eligibility criteria expanded, about 10 words
    • Site details revised
  2. Enrollment increased: 35 → 70 participants
    • Primary and study completion pushed from Jan 17, 2027 to Jun 21, 2027
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Boehringer Ingelheim
223 trials monitored
See 11 trials at risk
Obesity
3,874 trials monitored
See 152 trials at risk
The main objectives of this trial are to investigate safety, tolerability of alternative dose titration strategies and pharmacokinetics (PK) of BI 3034701 in participants with overweight / obesity and at least one weight related co-morbidity following subcutaneous administration.
Trial Details
NCT Number NCT07754474
Lead Sponsor Boehringer Ingelheim
Conditions
(from sponsor)		 Overweight, Obesity
Related terms Obesity, Overweight
Enrollment 70 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov